Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study.

Musim AlotaibiAhmed AliDuaa BakhshwinYasser AlatawiSultan AlotaibiAbdullah A Alhifany Badr AlharthiNasser AlharthiAwatef AlyazidiYasmeen AlharthiAziza Rashed Al-Rafiah

Published in: International journal of general medicine (2021)

The present study concluded that FPV and HCQ showed comparable efficacy in decrease mortality and oxygen requirements. FPV likely has a more favorable safety profile regarding cardiac toxicity. A randomized clinical trial with large patient numbers is recommended to confirm the effectiveness of these drugs in COVID-19 patients.

Keyphrases

sars cov
coronavirus disease
randomized controlled trial
systematic review
left ventricular
oxidative stress
case report
risk factors
type diabetes
cardiovascular disease
heart failure
coronary artery disease
respiratory syndrome coronavirus